Chang Yingzi, Dagat Lei Alena, Yusuf Aisha, Zahriya Yusuf, Staputyte Kotryna, Worley Emma, Holt Alex, Canuteson Natalie, Messieha Vereena, Halila Kasey
Department of Pharmacology, A.T. Still University, Kirksville College of Osteopathic Medicine, Kirksville, MO, 63501, USA.
Truman State University, Kirksville, MO, 63501, USA.
Curr Res Pharmacol Drug Discov. 2022 Mar 7;3:100094. doi: 10.1016/j.crphar.2022.100094. eCollection 2022.
Basic fibroblast growth factor (bFGF)-mediated vascular smooth muscle cell (VSMC) proliferation and migration play an important role in vascular injury-induced neointima formation and subsequent vascular restenosis, a major event that hinders the long-term success of angioplasty. The function of β-adrenergic receptors (β-ARs) in vascular injury-induced neointima formation has not yet been defined.
Our current study explored the possible role of β-ARs in vascular injury-induced neointima formation by testing its effects on bFGF-induced VSMC migration and proliferation.
β-AR expression in rat carotid arteries was examined at 14 days following a balloon catheter-induced injury. The effects of β-AR activation on bFGF-induced rat aortic smooth muscle cell proliferation, migration, and signaling transduction (including extracellular-signal-regulated kinase/mitogen activated protein kinase, ERK/MAPK and Protein kinase B, AKT) were tested.
We found that vascular injury induced upregulation of β-ARs in neointima. Pretreatment of VSMCs with a selective β-AR agonist, CL316,243 significantly potentiated bFGF-induced cell migration and proliferation, and ERK and AKT phosphorylation. Our results also revealed that suppressing phosphorylation of ERK and AKT blocked bFGF-induced cell migration and that inhibiting AKT phosphorylation reduced bFGF-mediated cell proliferation.
Our results suggest that activation of β-ARs potentiates bFGF-mediated effects on VSMCs by enhancing bFGF-mediated ERK and AKT phosphorylation and that β-ARs may play a role in vascular injury-induced neointima formation.
碱性成纤维细胞生长因子(bFGF)介导的血管平滑肌细胞(VSMC)增殖和迁移在血管损伤诱导的新生内膜形成及随后的血管再狭窄中起重要作用,血管再狭窄是阻碍血管成形术长期成功的主要事件。β-肾上腺素能受体(β-ARs)在血管损伤诱导的新生内膜形成中的功能尚未明确。
我们当前的研究通过测试其对bFGF诱导的VSMC迁移和增殖的影响,探讨β-ARs在血管损伤诱导的新生内膜形成中的可能作用。
在球囊导管诱导损伤后14天检测大鼠颈动脉中β-AR的表达。测试β-AR激活对bFGF诱导的大鼠主动脉平滑肌细胞增殖、迁移和信号转导(包括细胞外信号调节激酶/丝裂原活化蛋白激酶,ERK/MAPK和蛋白激酶B,AKT)的影响。
我们发现血管损伤诱导新生内膜中β-ARs上调。用选择性β-AR激动剂CL316,243预处理VSMCs可显著增强bFGF诱导的细胞迁移和增殖以及ERK和AKT磷酸化。我们的结果还显示,抑制ERK和AKT磷酸化可阻断bFGF诱导的细胞迁移,抑制AKT磷酸化可降低bFGF介导的细胞增殖。
我们的结果表明,β-ARs的激活通过增强bFGF介导的ERK和AKT磷酸化来增强bFGF对VSMCs的作用,并且β-ARs可能在血管损伤诱导的新生内膜形成中起作用。